Rask Invest Research Team

The Rask Invest research team produces daily ASX news and research on ASX-listed companies and funds. Join the conversation inside the free investor community. Click here to have your say.

99% of long-term investing is doing nothing; the other 1% changes your life

Rask Invest Research Team's latest insights

Today's ASX news

A deep dive into PME shares

Is the Pro Medicus Ltd (ASX:PME) share price undervalued? Here are 3 reasons you might want to consider PME shares.

Today's ASX news

An easy way to value SCG and REA shares

The Scentre Group (ASX:SCG) share price has risen 18.3% since the start of 2025. It’s probably worth asking, ‘is the SCG share price top value?’

Today's ASX news

I’m keeping an eye on COH shares in 2026

The Cochlear Ltd (ASX:COH) share price is down around 11.3% since the start of 2025. It’s probably worth asking, ‘is the COH share price priced to perfection?’

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.